NSCI Netscientific Plc

TIDMNSCI

RNS Number : 8379Q

NetScientific PLC

22 June 2015

NetScientific plc

Results of Annual General Meeting

London, UK - 22 June 2015 - NetScientific plc ("NetScientific" or "the Group", AIM: NSCI), the biomedical and healthcare technology group, announces that all resolutions proposed at today's Annual General Meeting have been duly passed.

As previously announced, Francois Martelet, the Company's new Chief Executive Officer, provided an update to shareholders, including his thoughts on the next steps for NetScientific. The Board intends to define clear value inflection points for the Company's leading assets and deliver value enhancing news flow across the Group. The presentation will be available on the Company's website later today.

As part of a review of the liquidity in the Company's shares, the Board also expressed its intention to consider a fundraising during the next 12 months to support the next stage of development in NetScientific's investment portfolio, with a focus on the Company's leading assets.

-Ends-

About NetScientific

NetScientific is a biomedical and healthcare technology group that funds and develops technologies that offer transformative benefits to people's lives and society through improved diagnosis, prognosis and treatment. For more information, please visit the website at www.netscientific.net.

Contact Details

 
 NetScientific                         Tel: +44 (0)77 2055 5752 
  Peter Thoms, CFO 
 Investec                              Tel: +44 (0)20 7597 4000 
  Gary Clarence / Daniel Adams 
 Instinctif Partners                   Tel: +44 (0)20 7457 2020 
  Melanie Toyne-Sewell / Jayne Crook    Email: netscientific@instinctif.com 
 

This information is provided by RNS

The company news service from the London Stock Exchange

END

RAGFTMTTMBBTBPA

Netscientific (LSE:NSCI)
Gráfico Histórico do Ativo
De Jun 2024 até Jul 2024

Netscientific (LSE:NSCI)
Gráfico Histórico do Ativo
De Jul 2023 até Jul 2024